Advanced treatment options and hair-loss clinics have continued to emerge — and researchers are making progress on finding ...
Eli Lilly (NYSE:LLY) announced an expansion of its LillyDirect digital healthcare platform to facilitate contact with ...
Significantly more adolescent patients receiving baricitinib had hair regrowth compared with patients receiving placebo.
Alys Pharmaceuticals, Inc. ("Alys"), an immune-dermatology focused company, today announces that the first patient has been dosed in its Phase IIa trial of ALY-101 in patients suffering from Alopecia ...